This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrington, L. E.
Right arrow Articles by Ahmed, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrington, L. E.
Right arrow Articles by Ahmed, R.

 Previous Article  |  Next Article 

Journal of Virology, April 2002, p. 3329-3337, Vol. 76, No. 7
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.7.3329-3337.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Recombinant Vaccinia Virus-Induced T-Cell Immunity: Quantitation of the Response to the Virus Vector and the Foreign Epitope

Laurie E. Harrington,1 Robbert van der Most,1 J. Lindsay Whitton,2 and Rafi Ahmed1*

Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322,1 Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 920372

Received 27 September 2001/ Accepted 2 January 2002

Recombinant vaccinia viruses (rVV) have been extensively used as vaccines, but there is little information about the total magnitude of the VV-specific T-cell response and how this compares to the immune response to the foreign gene(s) expressed by the rVV. To address this issue, we quantitated the T-cell responses to both the viral vector and the insert following the infection of mice with VV expressing a cytotoxic T lymphocyte (CTL) epitope (NP118-126) from lymphocytic choriomeningitis virus (LCMV). The LCMV epitope-specific response was quantitated by intracellular cytokine staining after stimulation with the specific peptide. To analyze the total VV-specific response, we developed a simple intracellular cytokine staining assay using VV-infected major histocompatibility complex class I and II matched cells as stimulators. Using this approach, we made the following determinations. (i) VV-NP118 induced potent and long-lasting CD8 and CD4 T-cell responses to the vector; at the peak of the response (~1 week), there were ~107 VV-specific CD8 T cells (25% of the CD8 T cells) and ~106 VV-specific CD4 T cells (~5% of the CD4 T cells) in the spleen. These numbers decreased to ~5 x 105 CD8 T cells (~5% frequency) and ~105 CD4 T cells (~0.5% frequency), respectively, by day 30 and were then stably maintained at these levels for >300 days. The size of this VV-specific T-cell response was comparable to that of the T-cell response induced following an acute LCMV infection. (ii) VV-specific CD8 and CD4 T cells were capable of producing gamma interferon (IFN-{gamma}), tumor necrosis factor alpha (TNF-{alpha}), and interleukin-2; all cells were able to make IFN-{gamma}, a subset produced both IFN-{gamma} and TNF-{alpha}, and another subset produced all three cytokines. (iii) The CD8 T-cell response to the foreign gene (LCMV NP118-126 epitope) was coordinately regulated with the response to the vector during all three phases (expansion, contraction, and memory) of the T-cell response. The total number of CD8 T cells responding to NP118-126 were ~20- to 30-fold lower than the number responding to the VV vector (~1% at the peak and 0.2% in memory). This study provides a better understanding of T-cell immunity induced by VV-based vaccines, and in addition, the technique described in the study can be readily extended to other viral vectors to determine the ratio of the T-cell response to the insert versus the vector. This information will be useful in optimizing prime-boost regimens for vaccination.

* Corresponding author. Mailing address: Emory Vaccine Center and Dept. of Microbiology and Immunology, G211 Rollins Research Building, 1510 Clifton Rd., Atlanta, GA 30322. Phone: (404) 727-3571. Fax: (404) 727-3722. E-mail: ra{at}microbio.emory.edu.

Journal of Virology, April 2002, p. 3329-3337, Vol. 76, No. 7
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.7.3329-3337.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Finn, J. D., Bassett, J., Millar, J. B., Grinshtein, N., Yang, T. C., Parsons, R., Evelegh, C., Wan, Y., Parks, R. J., Bramson, J. L. (2009). Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus. J. Virol. 83: 12027-12036 [Abstract] [Full Text]  
  • Takagi, A., Matsui, M., Ohno, S., Duan, H., Moriya, O., Kobayashi, N., Oda, H., Mori, M., Kobayashi, A., Taneichi, M., Uchida, T., Akatsuka, T. (2009). Highly Efficient Antiviral CD8+ T-Cell Induction by Peptides Coupled to the Surfaces of Liposomes. CVI 16: 1383-1392 [Abstract] [Full Text]  
  • Wang, Y., Flesch, I. E. A., Tscharke, D. C. (2009). Vaccinia Virus CD8+ T-Cell Dominance Hierarchies Cannot Be Altered by Prior Immunization with Individual Peptides. J. Virol. 83: 9008-9012 [Abstract] [Full Text]  
  • Fisicaro, P, Valdatta, C, Boni, C, Massari, M, Mori, C, Zerbini, A, Orlandini, A, Sacchelli, L, Missale, G, Ferrari, C (2009). Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58: 974-982 [Abstract] [Full Text]  
  • Zhao, Y., De Trez, C., Flynn, R., Ware, C. F., Croft, M., Salek-Ardakani, S. (2009). The Adaptor Molecule MyD88 Directly Promotes CD8 T Cell Responses to Vaccinia Virus. J. Immunol. 182: 6278-6286 [Abstract] [Full Text]  
  • Rahbar, R., Murooka, T. T., Fish, E. N. (2009). Role for CCR5 in Dissemination of Vaccinia Virus In Vivo. J. Virol. 83: 2226-2236 [Abstract] [Full Text]  
  • Xiao, Z., Casey, K. A., Jameson, S. C., Curtsinger, J. M., Mescher, M. F. (2009). Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN. J. Immunol. 182: 2786-2794 [Abstract] [Full Text]  
  • Salek-Ardakani, S., Arens, R., Flynn, R., Sette, A., Schoenberger, S. P., Croft, M. (2009). Preferential Use of B7.2 and Not B7.1 in Priming of Vaccinia Virus-Specific CD8 T Cells. J. Immunol. 182: 2909-2918 [Abstract] [Full Text]  
  • Salek-Ardakani, S., Moutaftsi, M., Crotty, S., Sette, A., Croft, M. (2008). OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells. J. Immunol. 181: 7969-7976 [Abstract] [Full Text]  
  • Kaufman, D. R., Goudsmit, J., Holterman, L., Ewald, B. A., Denholtz, M., Devoy, C., Giri, A., Grandpre, L. E., Heraud, J.-M., Franchini, G., Seaman, M. S., Havenga, M. J. E., Barouch, D. H. (2008). Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice. J. Virol. 82: 6829-6837 [Abstract] [Full Text]  
  • Jing, L., Davies, D. H., Chong, T. M., Chun, S., McClurkan, C. L., Huang, J., Story, B. T., Molina, D. M., Hirst, S., Felgner, P. L., Koelle, D. M. (2008). An Extremely Diverse CD4 Response to Vaccinia Virus in Humans Is Revealed by Proteome-Wide T-Cell Profiling. J. Virol. 82: 7120-7134 [Abstract] [Full Text]  
  • Day, S. L., Ramshaw, I. A., Ramsay, A. J., Ranasinghe, C. (2008). Differential Effects of the Type I Interferons {alpha}4, {beta}, and {epsilon} on Antiviral Activity and Vaccine Efficacy. J. Immunol. 180: 7158-7166 [Abstract] [Full Text]  
  • Berhanu, A., Wilson, R. L., Kirkwood-Watts, D. L., King, D. S., Warren, T. K., Lund, S. A., Brown, L. L., Krupkin, A. K., VanderMay, E., Weimers, W., Honeychurch, K. M., Grosenbach, D. W., Jones, K. F., Hruby, D. E. (2008). Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge. J. Virol. 82: 3517-3529 [Abstract] [Full Text]  
  • Bielinska, A. U., Chepurnov, A. A., Landers, J. J., Janczak, K. W., Chepurnova, T. S., Luker, G. D., Baker, J. R. Jr. (2008). A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine. CVI 15: 348-358 [Abstract] [Full Text]  
  • Suvas, P. K., Dech, H. M., Sambira, F., Zeng, J., Onami, T. M. (2007). Systemic and Mucosal Infection Program Protective Memory CD8 T Cells in the Vaginal Mucosa. J. Immunol. 179: 8122-8127 [Abstract] [Full Text]  
  • Xiao, Z., Mescher, M. F., Jameson, S. C. (2007). Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. JEM 204: 2667-2677 [Abstract] [Full Text]  
  • Fischer, M. A., Tscharke, D. C., Donohue, K. B., Truckenmiller, M. E., Norbury, C. C. (2007). Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming. J. Gen. Virol. 88: 2378-2386 [Abstract] [Full Text]  
  • Fang, C., Miwa, T., Shen, H., Song, W.-C. (2007). Complement-Dependent Enhancement of CD8+ T Cell Immunity to Lymphocytic Choriomeningitis Virus Infection in Decay-Accelerating Factor-Deficient Mice. J. Immunol. 179: 3178-3186 [Abstract] [Full Text]  
  • Mitra-Kaushik, S., Cruz, J., Stern, L. J., Ennis, F. A., Terajima, M. (2007). Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses. J. Immunol. 179: 1303-1312 [Abstract] [Full Text]  
  • Precopio, M. L., Betts, M. R., Parrino, J., Price, D. A., Gostick, E., Ambrozak, D. R., Asher, T. E., Douek, D. C., Harari, A., Pantaleo, G., Bailer, R., Graham, B. S., Roederer, M., Koup, R. A. (2007). Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses. JEM 204: 1405-1416 [Abstract] [Full Text]  
  • Xiao, Z., Curtsinger, J. M., Prlic, M., Jameson, S. C., Mescher, M. F. (2007). The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. Int Immunol 19: 733-743 [Abstract] [Full Text]  
  • Moutaftsi, M., Bui, H.-H., Peters, B., Sidney, J., Salek-Ardakani, S., Oseroff, C., Pasquetto, V., Crotty, S., Croft, M., Lefkowitz, E. J., Grey, H., Sette, A. (2007). Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses. J. Immunol. 178: 6814-6820 [Abstract] [Full Text]  
  • Kotturi, M. F., Peters, B., Buendia-Laysa, F. Jr., Sidney, J., Oseroff, C., Botten, J., Grey, H., Buchmeier, M. J., Sette, A. (2007). The CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus. J. Virol. 81: 4928-4940 [Abstract] [Full Text]  
  • Raue, H.-P., Slifka, M. K. (2007). Pivotal Advance: CTLA-4+ T cells exhibit normal antiviral functions during acute viral infection. J. Leukoc. Biol. 81: 1165-1175 [Abstract] [Full Text]  
  • Dasgupta, A., Hammarlund, E., Slifka, M. K., Fruh, K. (2007). Cowpox Virus Evades CTL Recognition and Inhibits the Intracellular Transport of MHC Class I Molecules. J. Immunol. 178: 1654-1661 [Abstract] [Full Text]  
  • Hovav, A.-H., Cayabyab, M. J., Panas, M. W., Santra, S., Greenland, J., Geiben, R., Haynes, B. F., Jacobs, W. R. Jr., Letvin, N. L. (2007). Rapid Memory CD8+ T-Lymphocyte Induction through Priming with Recombinant Mycobacterium smegmatis. J. Virol. 81: 74-83 [Abstract] [Full Text]  
  • Zaunders, J. J., Dyer, W. B., Munier, M. L., Ip, S., Liu, J., Amyes, E., Rawlinson, W., De Rose, R., Kent, S. J., Sullivan, J. S., Cooper, D. A., Kelleher, A. D. (2006). CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells.. J. Virol. 80: 10151-10161 [Abstract] [Full Text]  
  • Grayson, J. M., Weant, A. E., Holbrook, B. C., Hildeman, D. (2006). Role of Bim in Regulating CD8+ T-Cell Responses during Chronic Viral Infection.. J. Virol. 80: 8627-8638 [Abstract] [Full Text]  
  • Chavan, R., Marfatia, K. A., An, I. C., Garber, D. A., Feinberg, M. B. (2006). Expression of CCL20 and Granulocyte-Macrophage Colony-Stimulating Factor, but Not Flt3-L, from Modified Vaccinia Virus Ankara Enhances Antiviral Cellular and Humoral Immune Responses.. J. Virol. 80: 7676-7687 [Abstract] [Full Text]  
  • Yi, J. S., Holbrook, B. C., Michalek, R. D., Laniewski, N. G., Grayson, J. M. (2006). Electron Transport Complex I Is Required for CD8+ T Cell Function. J. Immunol. 177: 852-862 [Abstract] [Full Text]  
  • Tscharke, D. C., Woo, W.-P., Sakala, I. G., Sidney, J., Sette, A., Moss, D. J., Bennink, J. R., Karupiah, G., Yewdell, J. W. (2006). Poxvirus CD8+ T-Cell Determinants and Cross-Reactivity in BALB/c Mice.. J. Virol. 80: 6318-6323 [Abstract] [Full Text]  
  • Porter, B. B., Harty, J. T. (2006). The Onset of CD8+-T-Cell Contraction Is Influenced by the Peak of Listeria monocytogenes Infection and Antigen Display. Infect. Immun. 74: 1528-1536 [Abstract] [Full Text]  
  • Whitmire, J. K., Benning, N., Whitton, J. L. (2006). Precursor Frequency, Nonlinear Proliferation, and Functional Maturation of Virus-Specific CD4+ T Cells.. J. Immunol. 176: 3028-3036 [Abstract] [Full Text]  
  • Hel, Z., Tsai, W.-P., Tryniszewska, E., Nacsa, J., Markham, P. D., Lewis, M. G., Pavlakis, G. N., Felber, B. K., Tartaglia, J., Franchini, G. (2006). Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes. J. Immunol. 176: 85-96 [Abstract] [Full Text]  
  • Smith, C. L., Mirza, F., Pasquetto, V., Tscharke, D. C., Palmowski, M. J., Dunbar, P. R., Sette, A., Harris, A. L., Cerundolo, V. (2005). Immunodominance of Poxviral-Specific CTL in a Human Trial of Recombinant-Modified Vaccinia Ankara. J. Immunol. 175: 8431-8437 [Abstract] [Full Text]  
  • Jing, L., Chong, T. M., McClurkan, C. L., Huang, J., Story, B. T., Koelle, D. M. (2005). Diversity in the Acute CD8 T Cell Response to Vaccinia Virus in Humans. J. Immunol. 175: 7550-7559 [Abstract] [Full Text]  
  • Claassen, E. A. W., van der Kant, P. A. A., Rychnavska, Z. S., van Bleek, G. M., Easton, A. J., van der Most, R. G. (2005). Activation and Inactivation of Antiviral CD8 T Cell Responses during Murine Pneumovirus Infection. J. Immunol. 175: 6597-6604 [Abstract] [Full Text]  
  • Pasquetto, V., Bui, H.-H., Giannino, R., Mirza, F., Sidney, J., Oseroff, C., Tscharke, D. C., Irvine, K., Bennink, J. R., Peters, B., Southwood, S., Cerundolo, V., Grey, H., Yewdell, J. W., Sette, A. (2005). HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products. J. Immunol. 175: 5504-5515 [Abstract] [Full Text]  
  • Jelley-Gibbs, D. M., Brown, D. M., Dibble, J. P., Haynes, L., Eaton, S. M., Swain, S. L. (2005). Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. JEM 202: 697-706 [Abstract] [Full Text]  
  • Wherry, E. J., Blattman, J. N., Ahmed, R. (2005). Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic Vaccination. J. Virol. 79: 8960-8968 [Abstract] [Full Text]  
  • Obst, R., van Santen, H.-M., Mathis, D., Benoist, C. (2005). Antigen persistence is required throughout the expansion phase of a CD4+ T cell response. JEM 201: 1555-1565 [Abstract] [Full Text]  
  • Jackson, S. S., Ilyinskii, P., Philippon, V., Gritz, L., Yafal, A. G., Zinnack, K., Beaudry, K. R., Manson, K. H., Lifton, M. A., Kuroda, M. J., Letvin, N. L., Mazzara, G. P., Panicali, D. L. (2005). Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus. J. Virol. 79: 6554-6559 [Abstract] [Full Text]  
  • Buchan, S., Gronevik, E., Mathiesen, I., King, C. A., Stevenson, F. K., Rice, J. (2005). Electroporation as a "Prime/Boost" Strategy for Naked DNA Vaccination against a Tumor Antigen. J. Immunol. 174: 6292-6298 [Abstract] [Full Text]  
  • Chen, A. M., Khanna, N., Stohlman, S. A., Bergmann, C. C. (2005). Virus-Specific and Bystander CD8 T Cells Recruited during Virus-Induced Encephalomyelitis. J. Virol. 79: 4700-4708 [Abstract] [Full Text]  
  • Mathew, A., Terajima, M., West, K., Green, S., Rothman, A. L., Ennis, F. A., Kennedy, J. S. (2005). Identification of Murine Poxvirus-Specific CD8+ CTL Epitopes with Distinct Functional Profiles. J. Immunol. 174: 2212-2219 [Abstract] [Full Text]  
  • Williams, M. A., Bevan, M. J. (2004). Shortening the Infectious Period Does Not Alter Expansion of CD8 T Cells but Diminishes Their Capacity to Differentiate into Memory Cells. J. Immunol. 173: 6694-6702 [Abstract] [Full Text]  
  • McCurdy, L. H., Rutigliano, J. A., Johnson, T. R., Chen, M., Graham, B. S. (2004). Modified Vaccinia Virus Ankara Immunization Protects against Lethal Challenge with Recombinant Vaccinia Virus Expressing Murine Interleukin-4. J. Virol. 78: 12471-12479 [Abstract] [Full Text]  
  • Srinivasan, A., Foley, J., McSorley, S. J. (2004). Massive Number of Antigen-Specific CD4 T Cells during Vaccination with Live Attenuated Salmonella Causes Interclonal Competition. J. Immunol. 172: 6884-6893 [Abstract] [Full Text]  
  • Xu, R., Johnson, A. J., Liggitt, D., Bevan, M. J. (2004). Cellular and Humoral Immunity against Vaccinia Virus Infection of Mice. J. Immunol. 172: 6265-6271 [Abstract] [Full Text]  
  • Kim, S.-K., Welsh, R. M. (2004). Comprehensive Early and Lasting Loss of Memory CD8 T Cells and Functional Memory during Acute and Persistent Viral Infections. J. Immunol. 172: 3139-3150 [Abstract] [Full Text]  
  • Yang, T. C., Dayball, K., Wan, Y. H., Bramson, J. (2003). Detailed Analysis of the CD8+ T-Cell Response following Adenovirus Vaccination. J. Virol. 77: 13407-13411 [Abstract] [Full Text]  
  • Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., Ahmed, R. (2003). Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination. J. Immunol. 171: 4969-4973 [Abstract] [Full Text]  
  • Dunachie, S. J., Hill, A. V. S. (2003). Prime-boost strategies for malaria vaccine development. J. Exp. Biol. 206: 3771-3779 [Abstract] [Full Text]  
  • Terajima, M., Cruz, J., Raines, G., Kilpatrick, E. D., Kennedy, J. S., Rothman, A. L., Ennis, F. A. (2003). Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201-restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses. JEM 197: 927-932 [Abstract] [Full Text]  
  • Williams, M. A., Adams, A. B., Walsh, M. B., Shirasugi, N., Onami, T. M., Pearson, T. C., Ahmed, R., Larsen, C. P. (2003). Primary and Secondary Immunocompetence in Mixed Allogeneic Chimeras. J. Immunol. 170: 2382-2389 [Abstract] [Full Text]  
  • Woodberry, T., Gardner, J., Elliott, S. L., Leyrer, S., Purdie, D. M., Chaplin, P., Suhrbier, A. (2003). Prime Boost Vaccination Strategies: CD8 T Cell Numbers, Protection, and Th1 Bias. J. Immunol. 170: 2599-2604 [Abstract] [Full Text]  
  • Hel, Z., Nacsa, J., Tryniszewska, E., Tsai, W.-P., Parks, R. W., Montefiori, D. C., Felber, B. K., Tartaglia, J., Pavlakis, G. N., Franchini, G. (2002). Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses. J. Immunol. 169: 4778-4787 [Abstract] [Full Text]  
  • Kim, S.-K., Brehm, M. A., Welsh, R. M., Selin, L. K. (2002). Dynamics of Memory T Cell Proliferation Under Conditions of Heterologous Immunity and Bystander Stimulation. J. Immunol. 169: 90-98 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»